eCARTv5 Clinical Deterioration Suite (“eCART”) vs OM1 Patient Finder

AgileMD's eCARTv5 is designed for seamless integration into existing EHR workflows, providing real-time data and embedded clinical pathways to guide care, which suggests a highly intuitive user interface and a focus on minimizing clinician workload. OM1 Patient Finder, while powerful, focuses more on data analysis and patient identification for research and broader decision-making, with less emphasis on direct, real-time clinical workflow integration for bedside care.

eCARTv5 is an FDA-cleared Software as a Medical Device (SaMD) specifically designed to predict clinical deterioration (death or ICU transfer) in hospitalized adult patients, with extensive retrospective and prospective validation across millions of patient encounters and numerous peer-reviewed publications. OM1 Patient Finder focuses on identifying patients for target conditions using real-world data, which is valuable for research and population health, but it is not FDA-cleared for direct clinical decision support at the point of care for acute patient management.

Both AgileMD eCARTv5 and OM1 Patient Finder do not publicly disclose their pricing details, instead opting for tailored quotes based on client needs. This lack of transparency makes a direct comparison of pricing and value difficult without specific quotes for comparable scopes of work. Therefore, it is a tie in this dimension.

AgileMD's eCARTv5 is built for rapid, seamless implementation at scale within health systems, integrating directly into EHRs and operating behind multiple layers of security and compliance (HIPAA, SOC-II). It has been deployed in over 400 hospitals and used by over 150,000 clinical users, demonstrating significant enterprise adoption and stability. While OM1 Patient Finder is cloud-based and HIPAA compliant with API availability, its primary focus on research and data insights, rather than direct clinical workflow integration across an entire hospital system, suggests a different kind of enterprise readiness.

Both tools demonstrate significant innovation in their respective domains. AgileMD's eCARTv5 utilizes a gradient-boosted machine learning model with 97 variables for highly accurate, real-time clinical deterioration prediction, backed by over a decade of research. OM1 Patient Finder leverages its proprietary PhenOM AI model, trained on over a billion patient-years of real-world data, for advanced digital phenotyping, patient identification, and outcomes prediction, pushing boundaries in real-world evidence generation.

AgileMD provides a range of support and documentation, including peer-reviewed publications, a knowledge base, and direct contact options, indicating a robust support structure for clinical users. While OM1 highlights its scientific and consulting services and its expertise in data science, specific details about readily available user documentation or a dedicated support portal for the Patient Finder tool are less prominent.